TORONTO--(BUSINESS WIRE)--According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the market for electrophysiology (EP) mapping and ablation ...
Stereotaxis STXS recently submitted an application seeking FDA regulatory clearance for its MAGiC Sweep catheter, which is the first-ever robotically navigated high-density electrophysiology (EP) ...
Stereotaxis has announced the submission of the MAGiC Sweep™ catheter for FDA approval, marking the first high-density electrophysiological (EP) mapping catheter designed for robotic navigation using ...
BURLINGTON, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- CoreMap today announced it has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to extend ...
Enrollment completed ahead of schedule in the global IDE for Abbott (ABT)'s Volt™ PFA System Global FOCALFLEX trial now underway for Abbott's TactiFlex™ Duo Ablation Catheter, Sensor Enabled™ Advisor™ ...
- EnSite™ X EP System with EnSite Omnipolar Technology (OT) provides a 360-degree view of the heart, regardless of catheter orientation, for cardiac mapping without compromise ABBOTT PARK, Ill., Jan.
First-of-its-kind, all-in-one HD-mapping and dual energy (pulsed field and radiofrequency) ablation catheter Highly anticipated by electrophysiologists for its innovation and demonstrated safety and ...
COPENHAGEN, Denmark, June 16, 2025 /PRNewswire/ -- CathVision, a leader in advanced cardiac electrophysiology (EP) technology, has developed a new algorithmic tool (PFAnalyzer) to help physicians ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback